Browse the entire tale.

A new way to pay for chemotherapy Kaiser Health News staff writer Julie Appleby reviews: ‘Among the nation’s largest health insurers said today it is testing a new way to cover some cancer treatments, aiming to identify the best medicines – and limit earnings doctors make by dispensing in-workplace chemotherapy drugs’ . Browse the entire tale. This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an unbiased news service editorially, is a scheduled plan of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.‘Any shortage of these products is therefore due to decisions made by market regarding making or distribution,’ DEA spokeswoman Barbara Carreno, informed Reuters. The FDA openly disagrees with the DEA’s stringent quotas, the right times reported, and questions if the limit allows producers to select to make more costly versions of the pill than cheaper generics, creating ‘source and demand imbalances.’ The shortage is nothing new for a lot of with ADHD. Patients have already been scrambling to discover generic versions of extended-launch Adderall since May, CBS Information reported.